Health-related quality of life (HRQOL) with pembrolizumab (pembro) plus trastuzumab (tras) and chemotherapy (chemo) in first-line HER2-positive (HER2+) advanced gastric cancer: KEYNOTE-811 trial results Meeting Abstract
| Authors: | Janjigian, Y. Y.; Kawazoe, A.; Xu, J.; Lonardi, S.; Metges, J. P.; Wyrwicz, L. S.; Shen, L.; Ostapenko, Y.; Bilici, M.; Lowery, M. A.; Valderrama, A.; Guan, Y.; Li, K.; Shih, C. S.; Rha, S. Y. |
| Abstract Title: | Health-related quality of life (HRQOL) with pembrolizumab (pembro) plus trastuzumab (tras) and chemotherapy (chemo) in first-line HER2-positive (HER2+) advanced gastric cancer: KEYNOTE-811 trial results |
| Meeting Title: | 2024 ASCO Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2024 Jan 18-20 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-01-20 |
| Language: | English |
| ACCESSION: | WOS:001266680500267 |
| DOI: | 10.1200/JCO.2024.42.3_suppl.286 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 286 -- Source: Wos |
